{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:57:28Z","timestamp":1794959848846,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To analyze trends driving the increase in the 5-year survival rate of pancreatic cancer over the last decade with a focus across disease stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Pancreatic cancer survival data was analyzed by disease stage, age, and race\/ethnicity using the most recent data from the Surveillance, Epidemiology, and End Results (SEER) program. Stage distribution and survival rates were combined to evaluate the contribution of each stage to the overall survival rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The most recent SEER 17 data registry reports an overall 5-year survival rate for pancreatic cancer of 12%, with rates varying significantly across stages and age groups. The overall 5-year survival, irrespective of stage at the time of diagnosis, increased from 6% for patients diagnosed in 2004 to 12% for those diagnosed in 2015. During this same period, the incidence rate of distant disease decreased from 60% to 53%; however, the 5-year survival rate only increased from 2% to 3%, suggesting minimal advancements in treatment outcomes for individuals identified with distant disease at the time of diagnosis. In contrast, the 5-year survival rate for localized disease rose from 24% to 46%, while the stage distribution only slightly increased from 11% to 14% during the same period. Survival rates for distant disease at 4-, 3-, 2-year did not increase, however, the 1-year survival increased from 14% to 22% (2004\u20132019). These trends suggest progress in short-term outcomes, aligning with the availability of new FDA-approved treatments for advanced or metastatic disease with a median overall survival of &lt;1 year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This research confirms that the overall 5-year survival rate of 12% primarily reflects improved survival among those diagnosed with localized disease. Importantly, since only 14% of patients are diagnosed at this stage, the survival rate for most patients remains unchanged. This work also emphasizes the need for more research around variables that influence the overall 5-year survival rate, along with greater investment in early detection strategies to improve patient survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mpa.0000000000002489","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T15:00:17Z","timestamp":1744902017000},"page":"e530-e536","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":68,"title":["Factors Driving Pancreatic Cancer Survival Rates"],"prefix":"10.1097","volume":"54","author":[{"given":"Lola","family":"Rahib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"R1-20250625","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"R2-20250625","doi-asserted-by":"crossref","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R3-20250625","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: national cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"key":"R4-20250625","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"R5-20250625","first-page":"e60240","article-title":"Potential health disparities in the early detection and prevention of pancreatic cancer","volume":"16","author":"Yip-Schneider","year":"2024","journal-title":"Cureus"},{"key":"R6-20250625","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cam4.1277","article-title":"Disparities in cancer outcomes across age, sex, and race\/ethnicity among patients with pancreatic cancer","volume":"7","author":"Nipp","year":"2018","journal-title":"Cancer Med"},{"key":"R7-20250625","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s40615-022-01486-1","article-title":"Health disparities in presentation, treatment, genomic testing, and outcomes of pancreatic cancer in Hispanic and non-Hispanic patients","volume":"10","author":"Halder","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"key":"R8-20250625","doi-asserted-by":"crossref","first-page":"S-328","DOI":"10.1016\/S0016-5085(19)37654-1","article-title":"Sa1367\u2014half of sporadic pancreatic ductal adenocarcinoma patients receive minimal or no treatment: a population-based study at a tertiary care center","volume":"156","author":"De La Fuente","year":"2019","journal-title":"Gastroenterology"},{"key":"R9-20250625","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/02813432.2022.2069730","article-title":"Healthcare use in the year preceding a diagnosis of pancreatic cancer: a register-based cohort study in Denmark","volume":"40","author":"Rasmussen","year":"2022","journal-title":"Scand J Prim Health Care"},{"key":"R10-20250625","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jama.2019.9690","article-title":"Screening for pancreatic cancer","volume":"322","author":"Lucas","year":"2019","journal-title":"JAMA"},{"key":"R11-20250625","doi-asserted-by":"crossref","first-page":"20028","DOI":"10.1038\/s41598-023-46751-3","article-title":"Quantifying the potential benefits of early detection for pancreatic cancer through a counterfactual simulation modeling analysis","volume":"13","author":"Park","year":"2023","journal-title":"Sci Rep"},{"key":"R13-20250625","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ijc.30166","article-title":"Pancreatic cancer: wait times from presentation to treatment and survival in a population-based study","volume":"139","author":"Jooste","year":"2016","journal-title":"Intl J Cancer"},{"key":"R14-20250625","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.22.00298","article-title":"The multicenter cancer of pancreas screening study: impact on stage and survival","volume":"40","author":"Dbouk","year":"2022","journal-title":"JCO"},{"key":"R15-20250625","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models","volume":"32","author":"McCaffrey","year":"2013","journal-title":"Stat Med"},{"key":"R16-20250625","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12885-020-6710-1","article-title":"Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases","volume":"20","author":"Siebenh\u00fcner","year":"2020","journal-title":"BMC Cancer"},{"key":"R17-20250625","doi-asserted-by":"crossref","first-page":"1167508","DOI":"10.3389\/fendo.2023.1167508","article-title":"Comparison of prognosis after partial and total surgical resection for parathyroid carcinoma: an inverse probability of treatment weighting analysis of the SEER database","volume":"14","author":"Jin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R18-20250625","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R19-20250625","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"R20-20250625","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.ejca.2009.08.009","article-title":"The importance of early symptom recognition in the context of early detection and cancer survival","volume":"45","author":"Ott","year":"2009","journal-title":"Eur J Cancer"},{"key":"R21-20250625","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jnci\/djaa004","article-title":"Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis","volume":"112","author":"Blackford","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"R22-20250625","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med"},{"key":"R23-20250625","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/cncr.28794","article-title":"Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009","volume":"120","author":"Yang","year":"2014","journal-title":"Cancer"},{"key":"R24-20250625","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/cancers14020283","article-title":"Trends in the incidence and treatment of early-onset pancreatic cancer","volume":"14","author":"LaPelusa","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R25-20250625","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.pan.2020.07.410","article-title":"Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: stages of progression and potential benefits of early intervention: a retrospective study","volume":"20","author":"Singh","year":"2020","journal-title":"Pancreatology"},{"key":"R26-20250625","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MPA.0000000000001762","article-title":"Artificial intelligence and early detection of pancreatic cancer: 2020 summative review","volume":"50","author":"Kenner","year":"2021","journal-title":"Pancreas"},{"key":"R27-20250625","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/MPA.0000000000001882","article-title":"Early detection of pancreatic cancer: applying artificial intelligence to electronic health records","volume":"50","author":"Kenner","year":"2021","journal-title":"Pancreas"},{"key":"R28-20250625","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/heq.2019.0057","article-title":"Disparities in pancreatic cancer treatment and outcomes","volume":"3","author":"Noel","year":"2019","journal-title":"Health Equity"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:00:38Z","timestamp":1750816838000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000002489","relation":{},"ISSN":["1536-4828"],"issn-type":[{"value":"1536-4828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"2025-02-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}